Ligand Pharmaceuticals Inc (LGND)
116.55
+4.99
(+4.47%)
USD |
NASDAQ |
Nov 21, 16:00
116.89
+0.34
(+0.29%)
After-Hours: 20:00
Ligand Pharmaceuticals Price to Book Value: 2.626 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.506 |
| November 19, 2024 | 2.511 |
| November 18, 2024 | 2.508 |
| November 15, 2024 | 2.509 |
| November 14, 2024 | 2.593 |
| November 13, 2024 | 2.742 |
| November 12, 2024 | 2.712 |
| November 11, 2024 | 2.774 |
| November 08, 2024 | 2.724 |
| November 07, 2024 | 2.918 |
| November 06, 2024 | 2.626 |
| November 05, 2024 | 2.496 |
| November 04, 2024 | 2.458 |
| November 01, 2024 | 2.454 |
| October 31, 2024 | 2.357 |
| October 30, 2024 | 2.449 |
| October 29, 2024 | 2.577 |
| October 28, 2024 | 2.529 |
| October 25, 2024 | 2.494 |
| October 24, 2024 | 2.475 |
| October 23, 2024 | 2.384 |
| October 22, 2024 | 2.375 |
| October 21, 2024 | 2.381 |
| October 18, 2024 | 2.373 |
| October 17, 2024 | 2.362 |
| Date | Value |
|---|---|
| October 16, 2024 | 2.390 |
| October 15, 2024 | 2.328 |
| October 14, 2024 | 2.307 |
| October 11, 2024 | 2.296 |
| October 10, 2024 | 2.237 |
| October 09, 2024 | 2.302 |
| October 08, 2024 | 2.296 |
| October 07, 2024 | 2.289 |
| October 04, 2024 | 2.337 |
| October 03, 2024 | 2.280 |
| October 02, 2024 | 2.229 |
| October 01, 2024 | 2.260 |
| September 30, 2024 | 2.232 |
| September 27, 2024 | 2.295 |
| September 26, 2024 | 2.342 |
| September 25, 2024 | 2.328 |
| September 24, 2024 | 2.346 |
| September 23, 2024 | 2.349 |
| September 20, 2024 | 2.423 |
| September 19, 2024 | 2.475 |
| September 18, 2024 | 2.443 |
| September 17, 2024 | 2.457 |
| September 16, 2024 | 2.474 |
| September 13, 2024 | 2.469 |
| September 12, 2024 | 2.406 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8797
Minimum
Mar 16 2020
3.156
Maximum
Feb 09 2021
1.721
Average
1.712
Median
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals Inc | 2.790 |
| Agios Pharmaceuticals Inc | 1.948 |
| ADMA Biologics Inc | 21.71 |
| Pieris Pharmaceuticals Inc | 1.293 |
| AnaptysBio Inc | 7.641 |
Price to Book Value Related Metrics
| PE Ratio | 46.57 |
| PS Ratio | 13.85 |
| PEG Ratio | 0.2301 |
| Price to Free Cash Flow | 302.98 |
| Price | 116.55 |
| Earnings Yield | 2.15% |
| Market Cap | 2.209B |
| PEGY Ratio | 0.2301 |
| Operating PE Ratio | 117.44 |